MATTHEW MANTILLA: Open Payments
NPI 1235745605 · COOPERSTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 21 payments from 10 companies in 2025. Trend: 2023 $55 · 2024 $146 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $128 |
| Insmed, Inc. | 5 | $125 |
| Verona Pharma, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| GENZYME CORPORATION | 1 | $22 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Arikayce, NUCALA, Ohtuvayre, DUPIXENT, TRELEGY ELLIPTA, Brinsupri, FASENRA, LUMRYZ.
Industry payments across NY — which companies pay providers there.
